Professor & Director, John S. Dunn Chair in Disease Prevention, Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology -TAMHSC
The current focus is on genetic and epigenetic mechanisms in cancer development. The genetic basis of cancer is studied through cultured human cancer cells and whole animal approaches, including transgenic and knockout models. These models are employed to examine changes in oncogenes and tumor suppressors (e.g., K-ras, ²-catenin, APC) and the influence of chemoprotective agents and anticancer drug candidates. The epigenetic basis of cancer is studied through work on histone deacetylase (HDAC) inhibitors and changes in protein acetylation in both cancer cells and normal cells treated with dietary agents/anticancer drug candidates. Sulforaphane from broccoli, garlic organosulfur and organoselenium compounds and a short-chain fatty acid derived from gut fermentation of dietary fiber (butyrate) inhibit HDAC activity in human cancer cells and trigger growth arrest/apoptosis. The molecular mechanisms are pursued. To translate this work to humans, HDACs and protein acetylation changes are being examined in volunteers undergoing screening colonoscopy exams.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
Gulf Coast Cluster for Single Cell Omics
Training Grants
The Cancer Therapeutics Training Program (CTTP)
Appointments
Title
Department / School
Institution
Professor & Director, John S. Dunn Chair in Disease Prevention
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.